MPRI ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number AFAPRO28 |
Device Problems
Mechanical Problem (1384); Protective Measures Problem (3015)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/04/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that during a cryo ablation procedure, the high transseptal puncture and patient anatomy required the balloon catheter to be "over" manipulated.The over manipulation of the balloon caused it to rupture.The balloon catheter was immediately removed.It was also reported that a system notice was received indicating that the safety system detected blood in the catheter handle, the injection was stopped and the vacuum disabled.It was also reported that blood was visible in the balloon catheter.No blood was visible in the coaxial umbilical cable.The case was switched to and completed with radiofrequency. no patient complications have been reported as a result of this event.
|
|
Event Description
|
It was later reported that blood was not visible on the coaxial connector and the system notice was received fifteen seconds into tr eatment of the right superior pulmonary vein (rspv).
|
|
Manufacturer Narrative
|
Product event summary:the afapro28 balloon catheter with lot 07587 was returned and analyzed.The balloon catheter was visually inspected and functionally tested.External visual inspection of the balloon segment showed blood/fluid inside the balloon.The catheter smart chip data was downloaded and reviewed.Data indicated the catheter was used for (b)(4) applications on the reported event date.During functional testing, the console terminated the application and triggered system notice 50006 "indicating that the safety system detected blood in the catheter handle, the injection was stopped and the vacuum disabled." pressure testing of the outer balloon identified the outer balloon proximal bond was leaking and detached from the shaft.During inspection of the handle segment, blood/liquid was observed inside handle.In conclusion, the reported visible blood and the reported system notice 50006 were confirmed.The balloon catheter also failed the returned product inspection due to an outer balloon proximal bond detachment.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|